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Abstract: Screening of non-typhoidal Salmonella enterica clinical isolates (n=20) by PCR revealed the high prevalence 
of class 1 integrons (45%). Multidrug-resistant (MDR) phenotypes were observed in all integron-positive isolates, 
regardless of the serotype. A significant correlation was found between the MDR phenotype and the presence of class 1 
integrons in the isolates, especially in S. Typhimurium. 
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1. INTRODUCTION 
Multidrug-resistant (MDR) Salmonella enterica 
strains are considered as a significant threat to human 
health in both developed and developing countries. 
Association between class 1 integrons and MDR has 
been established for a number of S. eneterica 
serotypes [1-5]. Surveillance and epidemiological 
studies demonstrated a considerable geographic 
variation in the prevalence and types of integrons 
among clinical isolates [1, 2, 4, 5]. However, there is a 
lack of information on the occurrence of class 1 
integrons in Salmonella isolates in Armenia. Thus the 
aim of the present work was to investigate the 
prevalence of class 1 integrons and their relationship 
with the susceptibility to antibiotics in non-typhoidal 
Salmonella clinical isolates at this location. 
2. MATERIALS AND METHODS 
2.1. Isolates 
The study included a collection of 20 non-typhoidal 
Salmonella enterica subsp. enterica strains isolated in 
2011 from the patients at the “Nork” Clinical Hospital of 
Infectious Diseases (Yerevan, Armenia). Diagnosis 
was based on clinical presentations and laboratory 
analyses. Clinical presentations consistent with 
gastroenteritis were diarrhea, fever, nausea, vomiting, 
and abdominal cramps. Anamnesis of food consumed,  
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water sources, social gatherings, anybody else with a 
similar illness, and any recent history of travel was also 
recorded. For this investigation, only the patients that 
were not taking any type of medication including 
antibiotics before the hospital admission were chosen. 
Fecal samples were collected on the first or the second 
day of hospital admission. All the strains isolated from 
fecal samples confirmed to be Salmonella enterica by 
standard biochemical and serological tests. 
Biochemical tests for the identification of Salmonella 
were fermentation of glucose, negative urease 
reaction, lysine decarboxylase, negative indole test, 
H2S production, and fermentation of galactitol (dulcitol). 
Serotypes of Salmonella were determined using the 
standard Kauffman-White scheme with the use of 
commercially available polyvalent antisera for flagellar 
(H) and for lipopolysaccharide (O) antigens. 
For detoxification and rehydration, all patients were 
subjected to the standard infusion therapy. Based on 
the severity of the disease, 86% were placed on 
antibiotic therapy: (i) 38% received intravenous or 
intramuscular ceftriaxone (50mg/kg/day); (ii) 42% 
received peroral ciprofloxacin (0.5–1.0 g/day); and (iii) 
the rest were on the combination of one of the two 
drugs and trimethoprim/sulfamethoxazole. All study 
subjects (or parent/guardian if a child), gave their 
written consent to give fecal samples for the study. The 
study protocol was approved by the Ethics Committee 
of the Institute of Molecular Biology NAS RA (IORG 
number 0003427, Assurance number FWA00015042, 
and IRB number 00004079). 
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2.2. Antibiotic (AB) Susceptibility Tests 
The isolates were tested for the susceptibility to 
eight classes of antibiotics by disc diffusion. Standard 
disk diffusion method was used according to the 
guidelines of the Clinical and Laboratory Standards 
Institute (CLSI) [6]. The disks used (Micromaster 
Laboratories Pvt. Ltd., INDIA) contained ten antibiotics: 
streptomycin (S), gentamicin (G), amoxicillin/clavulanic 
acid (Au), ceftriaxone (Cx), trimethoprim/sulfametho-
xazole (Tm/S), sulfisoxazole (Su), ampicillin (A), chlor-
amphenicol (C), ciprofloxacin (Cp), and tetracycline (T). 
The isolates were classified as susceptible, 
intermediately resistant or fully resistant according to 
the CLSI guidelines [7].  
2.3. Detection of Class 1 Integrons 
Total DNA of isolates for PCR-amplification was 
prepared with the use of the FastDNA Kit (Qbiogene, 
Inc.), according to the manufacturer`s protocols. All 
strains were tested for the presence of class 1 
integrase-specific intI1 gene, variable segment of 
integrons, and 3`- conserved segment. Primers, PCR 
mix composition and PCR conditions used were as 
described previously [5]. PCR products were visualized 
by ethidium bromide staining after gel electrophoresis 
using 1.2% agarose. 
3. RESULTS 
Among 20 Salmonella clinical isolates tested nine 
isolates demonstrated the presence of intI1 (Table 1). 
PCR-amplification with the set of primers for 3`-
conserved segment indicated that all intI1
+
 strains 
produce the amplicons of the expected size (800bp) 
and thus were positive for the 3`-conserved segment 
too. The remaining Salmonella isolates did not 
generate PCR amplicons with any of the primer sets 
Table 1: Presence and Type of Class 1 Integrons, and Resistance Profile of Salmonella Clinical Isolates 
PCR-amplification target 
(primers set) 
Isolate 
number 
Salmonella 
Serotype intI1 
(1U-1D) 
VS
a 
(inF-inB) 
b.p. 
 
3`-CS
b
 
(qacE1-F 
sul1-B) 
Resistance profile  
Number of AM 
classes
c
 
1 S. Enteritidis - - - - 0 
2 S. Enteritidis - - - - 0 
3 S. Enteritidis - - - - 0 
4 S. Enteritidis - - - - 0 
5 S. Typhimurium - - - - 0 
6 S. Enteritidis - - - A 1 
7 S. Enteritidis - - - T* 1 
8 S. Typhimurium - - - AAu 2 
9 S. Typhimurium - - - AAu 2 
10 S. ser. I 4,[5],12:i:- - - - ASuTm/ST*C 4 
11 S. Enteritidis + 1000 + ASSuTm/SAu* 4 
12 S. Enteritidis - - - CpCSGTSuCx 6 
13 S. Enteritidis + 1000 + ACSSuTm/SAuCx* 6 
14 S. Enteritidis + 1000 + ACSSuTm/SAuCx 6 
15 other Salmonella + 1000 + ACSSuTm/SAuCx 6 
16 S. Typhimurium + 1000 + ACSSuTm/STAu* 6 
17 S. Typhimurium + 1500 + ACSSuTm/STAuCx 7 
18 S. Typhimurium + 1500 + ACSSuTm/STAu*Cx 7 
19 S. Typhimurium + 1500 + ACSSuTm/STAu*Cx 7 
20 S. Typhimurium + 1500 + ACSSuTm/STAuCx 7 
a
variable segment of integron; 
b
3`-conserved segment of integron; 
c
number of antimicrobial classes to which the isolate is resistant; *intermediate resistance to the 
drug. 
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used (Table 1) and, therefore, they were considered as 
integron-negative (intI1
-
). 
Thus, the results showed the presence of class 1 
integrons in 45% of the isolates (9 out of 20), five of 
which were identified as S. Typhimurium (55.6%), three 
isolates were identified as S. Enteritidis (33.3%), and 
one strain belonged to another Salmonella serotype 
(Table 1).  
PCR-amplification with the set of primers targeting 
the variable segment of integrons indicated the putative 
gene cassettes in all intI1
+
 strains (Table 1, Figure 1) 
since there were no “empty” integrons among them. All 
variable segments were represented by a single 
amplicon, and these amplicons were represented by 
two types: (i) those producing a 1000 bp amplicon (5 
isolates: 3 – S. Enteritidis, 1 – S. Typhimurium, and 1 – 
other Salmonella), and (ii) those producing an amplicon 
of about 1500 bp (4 isolates, all S. Typhimurium). 
All Salmonella clinical isolates were tested for the 
susceptibility to ten antibiotics. The highest level of 
susceptibility among the isolates tested was registered 
towards ciprofloxacin and gentamicin (95%). 
Resistance profiles and the number of antibiotic 
classes to which bacterial isolates were simultaneously 
resistant are summarized in Table 1. Based on these 
results, a comparative analysis of intI1
+
 and intI1
-
 
isolates was performed in order to reveal the 
association of antibiotic resistance phenotypes with 
integrons.  
Five isolates (25%) were sensitive to all antibiotics 
tested (Table 1, isolates 1-5). It is noteworthy that all 
these sensitive isolates were intI1
-
, with the majority 
belonging to the S. Enteritidis serotype (isolates 1-4). 
Resistance to one or two classes of antibiotics was 
observed in four isolates (20%), and they were also 
intI1
-
 (isolates 6-9). 
The results revealed that 55% of the isolates tested 
(11 of 20) were resistant to four or more antibiotics 
(isolates 10-20) thus displaying an MDR phenotype. 
Notably, about 82% of MDR isolates were intI1
+
 (9 out 
of 11) and the MDR phenotypes were observed in all 
integron-positive isolates, regardless of the serotype. 
Our study revealed only two intI1
- 
strains with MDR 
phenotypes (isolates 10 and 12), and their resistance 
profiles were markedly different from the profiles of 
other MDR strains.  
Currently, S. Enteritidis and S. Typhimurium are the 
predominant Salmonella serotypes encountered in 
clinical isolates in the region. Therefore, it was 
interesting to consider the MDR phenotype in these 
serotypes separately. 
Five out of eight S. Typhimurium isolates tested 
(62.5%) were resistant to at least six classes of 
antibiotics thus displaying an MDR phenotype (isolates 
16-20). Moreover, the isolate 16 exhibited ACSSuT 
resistance profile, typical of S. Typhimurium phage type 
DT104 [1, 2, 4]. It is known that among the S. 
Typhimurium DT104 strains the genes encoding for the 
 
Figure 1: Electrophoretic separation of PCR amplicons generated with the inF-inB primer set (specific for variable segment of 
class 1 integrons): 1 – H2O control; 2 – E. coli K12 (negative control), 3 – DNA mol. weight markers (DNA-Leiter kombi, CL 
22.1); 4-12 – Salmonella clinical isolates (4, 7, 8 – S. Enteritidis; 5, 6, 9, 10, 11 – S. Typhimurium; 12 – another S. enterica 
serotype). 
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mentioned penta-resistance profile are located in 
complex class 1 integrons, named In104, within 3´ end 
of the chromosomal genomic island SGI1 [1, 8]. SGI1 
is an integrative mobilizable element (IME), which can 
be transferred horizontally to other serotypes [9, 10]. 
The different types of SGI1 MDR complex integrons 
have been described in a wide variety of S. enterica 
serotypes [11-13, 18]. 
Noticeably, four of the remaining S. Typhimurium 
isolates with the MDR phenotype exhibited the same 
resistance profile to seven classes of antibiotics, 
ACSSuTAuCx (isolates 17-20). It is known as another 
important MDR phenotype of non-typhoidal Salmonella 
[14]. This profile includes resistance to 
amoxicillin/clavulanic acid (Au) and ceftriaxone (Cx) in 
addition to the penta-resistance profile of S. 
Typhimurium phage type DT104. 
Conspicuously, all MDR S. Typhimurium isolates 
were intI1
+
 while the remaining S. Typhimurium isolates 
were resistant to no more than two classes of 
antibiotics and all of them were intI1
-
. Thus, the strong 
association between MDR phenotype and the presence 
of class 1 integrons in the S. Typhimurium isolates was 
observed. 
Among the ten S. Enteritidis isolates tested, four 
(40%) were resistant at least to four antibiotic classes 
thus exhibiting an MDR phenotype. Moreover, three of 
them (isolates 12-14) exhibited the profiles of 
resistance to six antibiotic classes, closely resembling 
the aforementioned penta-resistance profile, typical of 
S. Typhimurium DT104. The differences were observed 
in resistance to one antibiotic (Table 1). It is notable 
that all 3 intI1
+
 S. Enteritidis isolates were MDR, 
similarly to intI1
+ 
S. Typhimurium. However, we 
revealed one S. Enteritidis isolate with the MDR 
phenotype, which was intI1
-
 (isolate 12).  
4. DISCUSSION 
In this work we focused on the prevalence of class 1 
integrons and comparative analysis of resistance 
profiles between integron-positive and integron-
negative isolates. Screening of Salmonella clinical 
isolates (n=20) detected the high prevalence of class 1 
integrons (45%) with the two types of embedded gene 
cassettes of about 1000 bp (predominantly in S. 
Enteritidis) and 1500 bp (S. Typhimurium only), 
occurring separately.  
Susceptibility testing indicated the high prevalence 
of MDR phenotypes in Salmonella clinical isolates 
(55%), with the higher percentage of S. Typhimurium 
(62.5%) compared to S. Enteritidis (40%). Notably, the 
MDR phenotypes were observed in all integron-positive 
isolates, regardless of the serotype. Our results 
revealed the more frequent occurrence of the MDR 
phenotype in integron-positive isolates compared to 
integron-negative, especially for S. Typhimurium 
isolates. The results indicated a strong association 
between the MDR phenotype and the presence of 
class 1 integrons in the S. Typhimurium isolates. Still, 
not all MDR Salmonella isolates were intI1
+
, two of 
them were found to be intI1
-
. The latter suggests that 
the repertoire of mobile genetic elements (MGEs) 
carrying the battery of antibiotic resistance genes in our 
Salmonella isolates is not limited to integrons but may 
be represented by other MGEs as well.  
In general antibiotic resistance profiles displayed 
certain serotype-specific features. Our results revealed 
that 25% of the isolates tested exhibited MDR 
phenotypes typical of non-typhoidal Salmonella, either 
with penta-resistance, ACSSuT, as in S. Typhimurium 
DT104, or resistance to 7 (ACSSuTAuCx) antibiotics 
[14]. It is of note that the latter isolates were S. 
Typhimurium, which is of great concern. Notably, 
among the S. Enteritidis isolates tested this MDR 
phenotype was not detected, although the closely 
related resistance patterns were observed. Although 
the resistance level in S. Enteritidis isolates is not as 
high as in S. Typhimurium, the MDR phenotype has 
become increasingly common in S. Enteritidis, which 
may compromise the therapy.  
5. CONCLUSIONS  
Thus, the results indicated the high prevalence of 
class 1 integrons and associated MDR among the 
clinical Salmonella enterica isolates in Armenia, which 
may complicate the choice of antibiotics for empirical 
therapy. Further studies are necessary to reveal the 
genetic background of MDR phenotypes and to 
estimate the genetic kinship among the isolates. More 
rigorous regulations should be imposed on antibiotic 
use, together with a vigilant epidemiological 
surveillance, to prevent the emergence and spread of 
MDR non-typhoidal Salmonella isolates.  
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